Blinklab Limited ASX: BB1 Share Price & Review

BB1 Overview

BB1 Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

BB1 Price Chart

Key Stats

Market Cap

AU$23.80M

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.2 - 0.59

Trade Value (12mth)

AU$21,135.00

1 week

-3.92%

1 month

15.29%

YTD

71.93%

1 year

78.18%

All time high

0.59

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Technology

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BB1 Announcements

Latest Announcements

Date	Announcements
09 July 25	Section 708A Notice × Section 708A Notice
09 July 25	Notification regarding unquoted securities - BB1 × Notification regarding unquoted securities - BB1
09 July 25	Notification regarding unquoted securities - BB1 × Notification regarding unquoted securities - BB1
09 July 25	Application for quotation of securities - BB1 × Application for quotation of securities - BB1
08 July 25	UNMC Engaged as Second Site in Main Phase of FDA510(k) Study × UNMC Engaged as Second Site in Main Phase of FDA510(k) Study
02 July 25	Section 708A Notice × Section 708A Notice
02 July 25	Application for quotation of securities - BB1 × Application for quotation of securities - BB1
30 June 25	Application for quotation of securities - BB1 × Application for quotation of securities - BB1
30 June 25	US Ethics Approval Received for the Main Phase of FDA510(k) × US Ethics Approval Received for the Main Phase of FDA510(k)
30 June 25	Section 708A Notice × Section 708A Notice
30 June 25	Results of General Meeting × Results of General Meeting
24 June 25	Response to ASX Price and Volume Query × Response to ASX Price and Volume Query
20 June 25	Change in substantial holding × Change in substantial holding
20 June 25	Change in substantial holding × Change in substantial holding
19 June 25	Ceasing to be a substantial holder × Ceasing to be a substantial holder
19 June 25	Ceasing to be a substantial holder × Ceasing to be a substantial holder
30 May 25	Letter to Shareholders & Proxy Form × Letter to Shareholders & Proxy Form
30 May 25	Notice of General Meeting & Proxy Form × Notice of General Meeting & Proxy Form
22 May 25	BlinkLab Engages First Clinical Site for Main Study Phase × BlinkLab Engages First Clinical Site for Main Study Phase
20 May 25	Change of Director's Interest Notice (RH) × Change of Director's Interest Notice (RH)
08 May 25	Application for quotation of securities - BB1 × Application for quotation of securities - BB1
08 May 25	Section 708A Notice × Section 708A Notice
01 May 25	Proposed issue of securities - BB1 × Proposed issue of securities - BB1
01 May 25	Successful Placement of A$7.66M to Underpin Growth Strategy × Successful Placement of A$7.66M to Underpin Growth Strategy
29 April 25	Trading Halt × Trading Halt

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BB1 Shortsell

Frequently Asked Questions

What is the current share price of Blinklab Limited (BB1:ASX)?

The current share price of Blinklab Limited (BB1:ASX) is AU$0.5.

What is the 52-week high share price for Blinklab Limited (BB1:ASX)?

The 52-week high share price for Blinklab Limited (BB1:ASX) is AU$0.59.

What is the 52-week low share price for Blinklab Limited (BB1:ASX)?

The 52-week low share price for Blinklab Limited (BB1:ASX)? is AU$0.20.

What is the dividend yield for Blinklab Limited (BB1:ASX)?

Blinklab Limited (BB1:ASX) does not pay a dividend.

What was Blinklab Limited (BB1:ASX) last dividend payment?

Blinklab Limited (BB1:ASX) does not pay a dividend.

What is the franking level for Blinklab Limited (BB1:ASX)?

Blinklab Limited (BB1:ASX) has a franking level of 0.0%.

In which sector is Blinklab Limited (BB1:ASX) classified?

Blinklab Limited (BB1:ASX) is classified in the Technology.

What is the current share price of Blinklab Limited (BB1:ASX)?

The current share price of Blinklab Limited (BB1:ASX) is AU$0.5.

What is the 52-week high share price for Blinklab Limited (BB1:ASX)?

The 52-week high share price for Blinklab Limited (BB1:ASX) is AU$0.59.

What is the 52-week low share price for Blinklab Limited (BB1:ASX)?

The 52-week low share price for Blinklab Limited (BB1:ASX)? is AU$0.20.

What is the dividend yield for Blinklab Limited (BB1:ASX)?

Blinklab Limited (BB1:ASX) does not pay a dividend.

What was Blinklab Limited (BB1:ASX) last dividend payment?

Blinklab Limited (BB1:ASX) does not pay a dividend.

What is the franking level for Blinklab Limited (BB1:ASX)?

Blinklab Limited (BB1:ASX) has a franking level of 0.0%.

In which sector is Blinklab Limited (BB1:ASX) classified?

Blinklab Limited (BB1:ASX) is classified in the Technology.

Company

Important

Get the latest insights and hot tips delivered right to your inbox

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

BB1 · ASX

Blinklab Limited (ASX:BB1)

AU$0.5

BB1 Overview

BB1 Health Scores

BB1 Price Chart

Key Stats

AU$23.80M

N/A

N/A

Dividends Overview

N/A

N/A

N/A

Market Data

Key Fundamentals

Other Data

BB1 Announcements

Latest Announcements

Section 708A Notice

Notification regarding unquoted securities - BB1

Notification regarding unquoted securities - BB1

Application for quotation of securities - BB1

UNMC Engaged as Second Site in Main Phase of FDA510(k) Study

Section 708A Notice

Application for quotation of securities - BB1

Application for quotation of securities - BB1

US Ethics Approval Received for the Main Phase of FDA510(k)

Section 708A Notice

Results of General Meeting

Response to ASX Price and Volume Query

Change in substantial holding

Change in substantial holding

Ceasing to be a substantial holder

Ceasing to be a substantial holder

Letter to Shareholders & Proxy Form

Notice of General Meeting & Proxy Form

BlinkLab Engages First Clinical Site for Main Study Phase

Change of Director's Interest Notice (RH)

Application for quotation of securities - BB1

Section 708A Notice

Proposed issue of securities - BB1

Successful Placement of A$7.66M to Underpin Growth Strategy

Trading Halt

Dividends

Key Stats

N/A

N/A

N/A

0.00%

Values and Recommendations

Key Stats

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

0.00%

0

N/A

N/A

N/A

N/A

Discover Short-sellingOpportunities

BB1 Shortsell

Related Companies

Frequently Asked Questions

Company

Company

Important

Discover
Short-selling
Opportunities